|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4 Pt 2
|
|
pubmed:dateCreated |
2003-9-22
|
|
pubmed:abstractText |
Alpha blocker therapy has been successfully used to decrease residual urine in children with complex neuropathic and nonneuropathic voiding dysfunction. We evaluated the safety and efficacy of using selective alpha blocker therapy for children with uncomplicated voiding dysfunction and underlying poor bladder emptying.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
170
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1514-5; discussion 1516-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14501648-Adolescent,
pubmed-meshheading:14501648-Adrenergic alpha-Antagonists,
pubmed-meshheading:14501648-Antibiotic Prophylaxis,
pubmed-meshheading:14501648-Child,
pubmed-meshheading:14501648-Child, Preschool,
pubmed-meshheading:14501648-Dose-Response Relationship, Drug,
pubmed-meshheading:14501648-Doxazosin,
pubmed-meshheading:14501648-Drug Administration Schedule,
pubmed-meshheading:14501648-Drug Therapy, Combination,
pubmed-meshheading:14501648-Female,
pubmed-meshheading:14501648-Humans,
pubmed-meshheading:14501648-Male,
pubmed-meshheading:14501648-Treatment Outcome,
pubmed-meshheading:14501648-Urinary Bladder, Neurogenic,
pubmed-meshheading:14501648-Urinary Incontinence,
pubmed-meshheading:14501648-Urinary Retention,
pubmed-meshheading:14501648-Urodynamics
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Alpha blocker therapy for children with dysfunctional voiding and urinary retention.
|
|
pubmed:affiliation |
Department of Urology, Indiana University School of Medicine, Indianapolis, USA. mpcain@iupui.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
